Acceptability, Barriers and Facilitators of a Communication Tool in Hospital Settings

Sponsor
Université de Sherbrooke (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05986929
Collaborator
Fondation Vitae (Other)
100
1
12
8.3

Study Details

Study Description

Brief Summary

The presence of appropriate systems to promote good communication within the care team is one of the ten important characteristics identified for effective interdisciplinary work. However, the current communication systems at the Eastern Townships University Health and Social Services Centre of the Sherbrooke University Hospital (SUH), an hospital setting in Sherbrooke (Quebec, Canada), are numerous, scattered and difficult to identify quickly. The bedside magnetized posters were developed to address this issue. The use of this kind of tool should improve teamwork, communication, and patient care. As the bedside magnetized posters are now well established on the stroke and geriatric units at the SUH, it is essential to evaluate their acceptability by staff members. In addition, identifying the barriers and facilitators to their use will support the team for eventual deployment in other care environments at the SUH.

Condition or Disease Intervention/Treatment Phase
  • Other: focus group
  • Other: electronic survey

Detailed Description

The objectives of the study are:
  1. To describe the acceptability of magnetic posters by staff members in the Neurology Department - Stroke Unit, where they are already well established, and in the Geriatric Department, where they are newly introduced.

  2. To identify barriers and facilitators to the use of magnetic posters to assist the team in an eventual deployment in other care environments at SUH.

Methods

A mixed sequential design will be used (quantitative, qualitative and observational). The study population will be staff working with inpatients in the neurology-stroke and geriatric units of SUH. Staff meeting the eligibility criteria will be invited to complete an electronic survey on the acceptability of the magnetic posters. The survey will consist of 15 closed questions relating to the use of the magnetic posters (e.g. frequency of poster consultation) and its acceptability (e.g. ease of use, poster content), one open question to gather suggestions for improving the tool and 6 socio-demographic questions. The survey will take approximately 10-15 minutes to complete, and responses will be recorded on the Research Centre on Aging's RedCap server for later analysis.

Also, a member of the research team will carry out observations on the neurology-stroke and geriatric units for one half-day, in order to collect data concerning, among other things, how the posters are used (e.g. where are the posters available to staff, which posters are used) and the characteristics of the patients for whom the posters are used.

Finally, two semi-structured group interviews, one for the neurology-stroke unit and one for the geriatric unit, will be facilitated by a member of the research team. Each group will be made up of 6 to 8 employees from a variety of professions, in order to be representative of the population under study and will last 30-60 minutes. The focus groups will address the facilitators and barriers to poster use for each respective unit. Discussions will be recorded and verbatims will be kept for later analysis.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Acceptability of a Communication Tool Using Bedside Magnetized Posters, as Well as Barriers and Facilitators to Its Use.
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Staff on the neurology and geriatric units

Staff that will participate in the electronic survey (N=100) and focus group (N=6-8)

Other: focus group
Two semi-structured group interviews, lasting 30-60 minutes, on facilitators and barriers to poster use by staff members (N=6-8).

Other: electronic survey
An electronic survey of 15 closed questions on the acceptability of the magnetic posters (N=100).

Outcome Measures

Primary Outcome Measures

  1. Acceptability [From the time the participants begin the electronic survey to the time their answers are sent off (approx. 15 to 20 minutes). There are no cut-off points for this outcome]

    questions on acceptability of the magnetic posters will be asked in the electronic survey

  2. Barriers and facilitators [This outcome will be measured during the participants' focus group, which should have a duration of approx. 60 minutes. There are no cut-off points for this outcome]

    questions on barriers and facilitators to poster use will be asked during the focus group

Secondary Outcome Measures

  1. Questionnaire on the use of the magnetic posters [This outcome will be measured during the observational half-day, which should have a duration of approx. 4 hours. There are no cut-off points for this outcome]

    during the observational half-day, how the posters are used (where they are used and which posters are used) in the stroke and geriatric units will be collected

  2. Characteristics of the patients [This outcome will be measured during the observational half-day, which should have a duration of approx. 4 hours. There are no cut-off points for this outcome]

    This outcome will be measured during the observational half-day, which should have a duration of approx. 4 hours.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adults aged 18 and over

  • employed by the SUH and working on stroke and geriatric units

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 CIUSSS de l'Estrie CHUS Sherbrooke Quebec Canada J1H 5N4

Sponsors and Collaborators

  • Université de Sherbrooke
  • Fondation Vitae

Investigators

  • Principal Investigator: Marie-Helene Milot, PhD, Université de Sherbrooke

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT05986929
Other Study ID Numbers:
  • 2024-5186
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 14, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Université de Sherbrooke

Study Results

No Results Posted as of Aug 14, 2023